NO913115L - I 17-stilling substituerte kortikoid-17-alkylkarbonater og fremgangsmaate for fremstilling derav. - Google Patents
I 17-stilling substituerte kortikoid-17-alkylkarbonater og fremgangsmaate for fremstilling derav.Info
- Publication number
- NO913115L NO913115L NO91913115A NO913115A NO913115L NO 913115 L NO913115 L NO 913115L NO 91913115 A NO91913115 A NO 91913115A NO 913115 A NO913115 A NO 913115A NO 913115 L NO913115 L NO 913115L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- halogen
- sulfonic acid
- local
- corticoid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4025342A DE4025342A1 (de) | 1990-08-10 | 1990-08-10 | In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO913115D0 NO913115D0 (no) | 1991-08-09 |
NO913115L true NO913115L (no) | 1992-02-11 |
Family
ID=6411982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91913115A NO913115L (no) | 1990-08-10 | 1991-08-09 | I 17-stilling substituerte kortikoid-17-alkylkarbonater og fremgangsmaate for fremstilling derav. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5362721A (es) |
EP (1) | EP0470617A3 (es) |
JP (1) | JPH0641187A (es) |
KR (1) | KR920004407A (es) |
AU (1) | AU646066B2 (es) |
CA (1) | CA2048841A1 (es) |
CZ (1) | CZ279875B6 (es) |
DE (1) | DE4025342A1 (es) |
EC (1) | ECSP941049A (es) |
EG (1) | EG19928A (es) |
FI (1) | FI913775A (es) |
HU (1) | HU211994B (es) |
IE (1) | IE912827A1 (es) |
IL (1) | IL99135A (es) |
LT (1) | LT3374B (es) |
LV (1) | LV10459B (es) |
MX (1) | MX9100613A (es) |
NO (1) | NO913115L (es) |
PT (1) | PT98605A (es) |
RU (1) | RU2060997C1 (es) |
TW (1) | TW203056B (es) |
ZA (1) | ZA916291B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4328819A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE4333920A1 (de) | 1993-10-05 | 1995-04-13 | Hoechst Ag | Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
US5981517A (en) * | 1996-05-09 | 1999-11-09 | Soft Drugs, Inc. | Androstene derivatives |
GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
AR032471A1 (es) | 2000-08-05 | 2003-11-12 | Glaxo Group Ltd | Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
CA2445839A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
US20040248867A1 (en) * | 2001-06-12 | 2004-12-09 | Keith Biggadike | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
JP5227593B2 (ja) * | 2005-02-04 | 2013-07-03 | アメリカ合衆国 | ナンドロロン17β−カーボネート |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
GB0523251D0 (en) * | 2005-11-15 | 2005-12-21 | Glaxo Group Ltd | Novel compounds |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
UA111867C2 (uk) | 2011-11-11 | 2016-06-24 | Аллерган, Інк. | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ І СПОСІБ ЗАСТОСУВАННЯ ПОХІДНИХ 4-ПРЕГНЕН-11β-17-21-ТРІОЛ-3,20-ДІОНУ |
WO2023088308A1 (zh) * | 2021-11-16 | 2023-05-25 | 石家庄迪斯凯威医药科技有限公司 | 一种具有抗耐药性的抗菌化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1668079B2 (de) | 1968-01-18 | 1976-09-16 | Hoechst Ag, 6000 Frankfurt | Dialkylorthocarbonate von 17alpha, 21-dihydroxysteroiden und verfahren zu ihrer herstellung |
DE2735110A1 (de) * | 1977-08-04 | 1979-02-15 | Hoechst Ag | Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung |
DE2817988A1 (de) * | 1978-04-25 | 1979-11-08 | Hoechst Ag | Corticoid 17-alkylcarbonate und verfahren zu deren herstellung |
SE449106B (sv) * | 1980-07-10 | 1987-04-06 | Otsuka Pharma Co Ltd | Steroid med anti-inflammatorisk verkan samt komposition innehallande denna |
AU558725B2 (en) * | 1983-09-07 | 1987-02-05 | Mitsubishi Kasei Corporation | Corticoid derivatives |
-
1990
- 1990-08-10 DE DE4025342A patent/DE4025342A1/de not_active Withdrawn
-
1991
- 1991-02-22 TW TW080101348A patent/TW203056B/zh active
- 1991-08-08 HU HU912643A patent/HU211994B/hu not_active IP Right Cessation
- 1991-08-08 EG EG47991A patent/EG19928A/xx active
- 1991-08-08 CZ CS912461A patent/CZ279875B6/cs unknown
- 1991-08-08 PT PT98605A patent/PT98605A/pt not_active Application Discontinuation
- 1991-08-08 IL IL9913591A patent/IL99135A/en not_active IP Right Cessation
- 1991-08-08 RU SU915001317A patent/RU2060997C1/ru active
- 1991-08-08 EP EP19910113338 patent/EP0470617A3/de not_active Ceased
- 1991-08-08 FI FI913775A patent/FI913775A/fi not_active Application Discontinuation
- 1991-08-09 AU AU82560/91A patent/AU646066B2/en not_active Ceased
- 1991-08-09 ZA ZA916291A patent/ZA916291B/xx unknown
- 1991-08-09 NO NO91913115A patent/NO913115L/no unknown
- 1991-08-09 CA CA002048841A patent/CA2048841A1/en not_active Abandoned
- 1991-08-09 IE IE282791A patent/IE912827A1/en unknown
- 1991-08-09 KR KR1019910013758A patent/KR920004407A/ko not_active Application Discontinuation
- 1991-08-09 MX MX9100613A patent/MX9100613A/es not_active IP Right Cessation
- 1991-08-09 JP JP3223670A patent/JPH0641187A/ja active Pending
-
1993
- 1993-02-08 US US08/015,041 patent/US5362721A/en not_active Expired - Fee Related
- 1993-05-07 LV LVP-93-302A patent/LV10459B/en unknown
- 1993-06-25 LT LTIP709A patent/LT3374B/lt not_active IP Right Cessation
-
1994
- 1994-02-28 EC EC1994001049A patent/ECSP941049A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2048841A1 (en) | 1992-02-11 |
IE912827A1 (en) | 1992-02-12 |
HU912643D0 (en) | 1992-01-28 |
HU211994B (en) | 1996-01-29 |
RU2060997C1 (ru) | 1996-05-27 |
MX9100613A (es) | 1992-04-01 |
EP0470617A3 (en) | 1992-04-01 |
DE4025342A1 (de) | 1992-02-13 |
AU646066B2 (en) | 1994-02-03 |
LV10459A (lv) | 1995-02-20 |
EG19928A (en) | 1996-07-31 |
LV10459B (en) | 1995-08-20 |
NO913115D0 (no) | 1991-08-09 |
TW203056B (es) | 1993-04-01 |
FI913775A0 (fi) | 1991-08-08 |
HUT59155A (en) | 1992-04-28 |
CS246191A3 (en) | 1992-03-18 |
AU8256091A (en) | 1992-02-13 |
LTIP709A (en) | 1995-01-31 |
FI913775A (fi) | 1992-02-11 |
ZA916291B (en) | 1992-04-29 |
LT3374B (en) | 1995-08-25 |
IL99135A0 (en) | 1992-07-15 |
KR920004407A (ko) | 1992-03-27 |
CZ279875B6 (cs) | 1995-07-12 |
US5362721A (en) | 1994-11-08 |
EP0470617A2 (de) | 1992-02-12 |
IL99135A (en) | 1995-12-08 |
JPH0641187A (ja) | 1994-02-15 |
PT98605A (pt) | 1992-06-30 |
ECSP941049A (es) | 1994-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO913115L (no) | I 17-stilling substituerte kortikoid-17-alkylkarbonater og fremgangsmaate for fremstilling derav. | |
NZ190343A (en) | Benzyl esters and arthropodicidal compositions also intermediates | |
NO843298L (no) | Nye karboksylsyreestere | |
NO943701L (no) | Kortikoid-17,21-dikarboksylsyreester samt kortikosteroid-17-karboksylsyreester-21-karbonsyreester, fremgangsmåte for fremstilling derav og legemiddel inneholdende disse | |
DK0984934T3 (da) | Hidtil ukendte oralt aktive jern(III)chelateringsmidler | |
SE8302823L (sv) | Komposition baserad pa flourklorvete, fosforsyraester och karboxylsyra | |
ATE53845T1 (de) | Thionophosphonsaeureester. | |
GB1078092A (en) | Anthraquinone dyestuffs | |
AU5036279A (en) | Substituted cyclopentenones | |
DE3579164D1 (de) | Neue kohlensaeureester. | |
JPS5540730A (en) | Stabilized polyphenylene oxide resin composition | |
SE7708142L (sv) | 5-(2-furoyl)-, 5-(2-tenoyl)-, 5-(3-furoyl)- och 5-(3-tenoyl)-1,2-dihydro-3h-pyrrolo (1,2-a) pyrrol-1-karbonsyraderivat och sett att framstella desamma | |
GB1533390A (en) | Detergent compositions | |
GB894068A (en) | Improvements in or relating to color photography | |
IE43248L (en) | Araliphatic dihalogen compounds. | |
JPS5446758A (en) | Higher fatty acid ester | |
SE7700490L (sv) | Hypolipidemiska p-aminobensoesyror | |
GB1021382A (en) | Substituted phenyl aryl ketones | |
SE8401280L (sv) | Mellanprodukter och forfaraden for framstellning derav | |
ES418421A1 (es) | Un procedimiento para la preparacion de nuevos 17-aza este-roides sustituidos en la posicion 21. | |
JPS54138551A (en) | Novel asymmetric synthesis of optically active 2-alkanoyl- 1,2,3,4-tetrahydro-2-naphthol compound | |
FI880384A0 (fi) | Nya imidazo- och triazolotiadiaziner, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter. | |
SE7905060L (sv) | Nya 1-pyrrol- och 1-pyrrolidin-karboxylsyraderivat och sett for framstellning derav | |
GB1024802A (en) | New derivatives of glycyrrhetinic acid | |
ES8104179A1 (es) | Procedimiento para la preparacion de esteres de 2-(6-metoxi-2-naftil)propilo |